IN2013CN02165A - - Google Patents
Download PDFInfo
- Publication number
- IN2013CN02165A IN2013CN02165A IN2165CHN2013A IN2013CN02165A IN 2013CN02165 A IN2013CN02165 A IN 2013CN02165A IN 2165CHN2013 A IN2165CHN2013 A IN 2165CHN2013A IN 2013CN02165 A IN2013CN02165 A IN 2013CN02165A
- Authority
- IN
- India
- Prior art keywords
- depot
- water
- mixture
- group
- agent selected
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 abstract 1
- 229930182566 Gentamicin Natural products 0.000 abstract 1
- 108010059993 Vancomycin Proteins 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229960002518 gentamicin Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000003002 pH adjusting agent Substances 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229960003165 vancomycin Drugs 0.000 abstract 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 abstract 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2010/061015 WO2012023955A1 (en) | 2010-08-20 | 2010-12-17 | Phospholipid depot |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2013CN02165A true IN2013CN02165A (https=) | 2015-09-25 |
Family
ID=54434776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2165CHN2013 IN2013CN02165A (https=) | 2010-12-17 | 2010-12-17 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2013CN02165A (https=) |
-
2010
- 2010-12-17 IN IN2165CHN2013 patent/IN2013CN02165A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX366099B (es) | Deposito de fosfolipidos. | |
| WO2012136969A3 (en) | Ophthalmic treatments | |
| WO2011113855A3 (en) | Pharmaceutical composition for treatment of increased intraocular pressure | |
| WO2009028495A1 (ja) | 真菌性皮膚炎用剤 | |
| NZ610346A (en) | Hyaluronic acid based formulations | |
| MX2013002932A (es) | Formulaciones agricolas liquidas de estabilidad mejorada. | |
| WO2011058474A8 (en) | N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors | |
| MX2011013201A (es) | Composiciones para tratar adiccion a drogas y para mejorar comportamiento relacionado a la adiccion. | |
| MX2013002603A (es) | Composicion de aceite y metodo para producir la misma. | |
| WO2009149418A3 (en) | Compositions for the in vivo delivery of rnai agents | |
| WO2010111267A3 (en) | Personal-care composition comprising a cationic active | |
| WO2023114937A3 (en) | Fluorinated cationic lipids for use in lipid nanoparticles | |
| MX360389B (es) | Formulacion farmaceutica o nutraceutica resistente a fluidos gastricos que comprende una o mas sales de acido alginico. | |
| WO2011087548A3 (en) | Therapeutic compositions and methods for targeted delivery of active agents | |
| MX2013009253A (es) | Formulaciones multiparticuladas de l-mentol y metodos relacionados. | |
| MX2012012846A (es) | Composicion oftalmica. | |
| NZ700972A (en) | Preservative system for emulsion-based therapeutic topical formulations | |
| WO2011091225A3 (en) | Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect | |
| WO2020138791A3 (ko) | 토파시티닙 또는 그의 약제학적으로 허용되는 염을 함유한 서방성 제제 및 그의 제조방법 | |
| WO2018234871A3 (en) | COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE | |
| IL186707A (en) | Mitotic quinine inhibitors and medical preparations containing them | |
| NZ591204A (en) | Pharmaceutical compositions and methods for stabilizing the same | |
| WO2018187617A8 (en) | Compositions and uses of locally-applied antimicrobial synthetic cationic polypeptide(s) with enhanced performance and safety | |
| WO2011073222A3 (de) | Hyperverzweigte polyester mit hydrophobem kern zur solubilisierung schwerlöslicher wirkstoffe | |
| NZ608406A (en) | Use of storage stable viscous phospholipid depot to treat wounds |